VELCADE Trademark

Trademark Overview

On Friday, April 11, 2008, a trademark application was filed for VELCADE with the United States Patent and Trademark Office. The USPTO has given the VELCADE trademark a serial number of 77445948. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 11, 2018. This trademark is owned by Millennium Pharmaceuticals, Inc.. The VELCADE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, proteasome inhibitors; pharmaceutical preparations for treatment of myelomas [, leukemias] and cancers; pharmaceutical preparations for use in chemotherapy
velcade

General Information

Serial Number77445948
Word MarkVELCADE
Filing DateFriday, April 11, 2008
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 11, 2018
Registration Number3659030
Registration DateTuesday, July 21, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 7, 2008

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "VELCADE" and an arc with a triangle on the end forming a curving arrow beginning to the left of the word and pointing down into the "V" in "VELCADE".
Goods and ServicesPharmaceuticals, namely, proteasome inhibitors; pharmaceutical preparations for treatment of myelomas [, leukemias] and cancers; pharmaceutical preparations for use in chemotherapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2008
Primary Code005
First Use Anywhere DateTuesday, March 29, 2005
First Use In Commerce DateFriday, March 27, 2009

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, December 11, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, December 11, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, December 11, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, December 11, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 28, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, July 21, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 2, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, February 2, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, February 2, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 23, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 21, 2009REGISTERED-PRINCIPAL REGISTER
Friday, June 12, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 29, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 8, 2009STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 23, 2009USE AMENDMENT FILED
Friday, May 8, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 23, 2009TEAS STATEMENT OF USE RECEIVED
Tuesday, December 30, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 26, 2008ASSIGNED TO EXAMINER
Tuesday, October 7, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2008NOTICE OF PUBLICATION
Friday, August 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 28, 2008ASSIGNED TO LIE
Wednesday, August 20, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 7, 2008EXAMINER'S AMENDMENT MAILED
Wednesday, August 6, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, August 6, 2008EXAMINERS AMENDMENT -WRITTEN
Friday, July 25, 2008ASSIGNED TO EXAMINER
Wednesday, April 16, 2008NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, April 15, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

velcade pharmaceutical preparations leukemias cancers chemotherapy myelomas treatment inhibitors namely pharmaceuticals